Form 4 Tracker
Adaptive Biotechnologies Corp
ADPT

58 insider filings · Latest: Aug 10, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 3, 2026Mar 6 1:05 AMMichelle Renee GriffinDirector
Sale
48,044$15.30$735.1K15,394(D)

View →

Mar 5, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Sale
30,941$16.00$495.1K575,235(D)

View →

Mar 4, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Sale
30,941$16.60$513.6K579,573(D)

View →

Mar 3, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Sale
30,941$15.67$484.8K583,911(D)

View →

Mar 3, 2026Mar 5 12:58 AMHarlan S RobinsChief Scientific Officer
Sale
14,233$16.52$235.1K1,155,291(D)

View →

Mar 2, 2026Mar 5 12:58 AMHarlan S RobinsChief Scientific Officer
Sale
10,000$15.72$157.2K1,169,524(D)

View →

Mar 3, 2026Mar 4 12:51 AMChad M RobinsDirector, CEO and Chairman
Sale
53,083$15.52$823.8K1,934,247(D)

View →

Mar 2, 2026Mar 4 12:51 AMChad M RobinsDirector, CEO and Chairman
Sale
289,024$15.82$4.6M1,987,330(D)

View →

Feb 27, 2026Mar 4 12:51 AMChad M RobinsDirector, CEO and Chairman
Sale
182,891$15.99$2.9M2,276,354(D)

View →

Mar 3, 2026Mar 3 9:59 PMHarlan Robins
Proposed Sale
14,233$16.08$228.9K

View →

Mar 3, 2026Mar 3 9:59 PMChad Robins
Proposed Sale
53,083$16.08$853.6K

View →

Mar 3, 2026Mar 3 9:50 PMJULIE RUBINSTEIN
Proposed Sale
1,206,661$16.12$19.5M

View →

Mar 3, 2026Mar 3 9:50 PMMICHELLE GRIFFIN
Proposed Sale
48,044$16.12$774.5K

View →

Mar 2, 2026Mar 2 10:24 PMHarlan Robins
Proposed Sale
10,000$16.12$161.2K

View →

Mar 2, 2026Mar 2 10:24 PMChad Robins
Proposed Sale
289,024$16.12$4.7M

View →

Feb 27, 2026Feb 27 9:47 PMChad Robins
Proposed Sale
182,891$16.02$2.9M

View →

Feb 4, 2026Feb 7 12:30 AMKyle PiskelChief Financial Officer
Sale
2,145$18.46$39.6K216,637(D)

View →

Feb 3, 2026Feb 5 12:48 AMHarlan S RobinsChief Scientific Officer
Sale
8,120$19.00$154.3K1,179,524(D)

View →

Feb 2, 2026Feb 5 12:48 AMHarlan S RobinsChief Scientific Officer
Sale
34,668$18.60$644.8K1,187,644(D)

View →

Feb 2, 2026Feb 5 12:37 AMChad M RobinsDirector, CEO and Chairman
Sale
124,998$18.44$2.3M2,459,245(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 12, 2026Mar 14 1:36 AMJulie RubinsteinPresident and COO
Option Exercise
14,722$6.5577,549(D)

View →

Mar 11, 2026Mar 14 1:36 AMJulie RubinsteinPresident and COO
Option Exercise
14,722$6.5592,271(D)

View →

Mar 10, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
15,122$12.14403,539(D)

View →

Mar 9, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14403,939(D)

View →

Mar 6, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14415,820(D)

View →

Mar 3, 2026Mar 6 1:05 AMMichelle Renee GriffinDirector
Option Exercise
48,044$3.990(D)

View →

Mar 5, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14427,701(D)

View →

Mar 4, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14439,582(D)

View →

Mar 3, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14451,463(D)

View →

Feb 4, 2026Feb 7 12:30 AMKyle PiskelChief Financial Officer
Option Exercise
2,145$12.142,146(D)

View →

← Previous

Page 3 of 3